D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea · Delayed Price · Currency is KRW 61,000
+2,200 (3.74%)
May 21, 2026, 1:30 PM KST
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 2.58 trillion as of May 20, 2026. Its market cap has increased by 304.97% in one year.
Market Cap
2.58T
Enterprise Value
2.55T
Revenue
4.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
61,000.00
Market Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 2.58T, an increase of 578.60%. That is a compound annual growth rate of 154.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 2.58T | -35.55% |
| Dec 30, 2025 | 4.00T | 678.13% |
| Dec 30, 2024 | 513.61B | 35.32% |
| May 2, 2024 | 379.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LigaChem Biosciences | 7.05T |
| HLB Co., Ltd. | 6.68T |
| Peptron | 6.05T |
| Voronoi | 4.79T |
| OliX Pharmaceuticals | 3.39T |
| PharmaResearch | 3.24T |
| SK bioscience | 3.18T |
| Hugel | 2.82T |